Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy

Left ventricular hypertrophy (LVH) is a pivotal manifestation of hypertensive organ damage associated with an increased cardiovascular risk. However, early diagnostic biomarkers for assessing LVH in patients with hypertension (HT) remain indefinite. Here, multiple bioinformatics tools combined with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Aging (Albany, NY.) NY.), 2022-02, Vol.14 (3), p.1508-1528
Hauptverfasser:	Li, Tiegang, Wang, Weiqi, Gan, Wenqiang, Lv, Silin, Zeng, Zifan, Hou, Yufang, Yan, Zheng, Zhang, Rixin, Yang, Min
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - metabolism Computational Biology Heart Ventricles Humans Hypertension - genetics Hypertension - metabolism Hypertension - pathology Hypertrophy, Left Ventricular - genetics Hypertrophy, Left Ventricular - metabolism Hypertrophy, Left Ventricular - pathology Membrane Proteins - genetics Membrane Proteins - metabolism Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!